Odense Investor Summit
Biotech & Life ScienceAbout the event
Odense Investor Summit – Biotech & Life Science bridges capital-seeking companies with investors, and gather the ecosystems of the Biotech, and Life Science industries. The stage will feature compelling investor cases, along with insightful reflections and valuable learning opportunities related to investing in the biotech and life science industries in today’s market.
Thanks to all who participated in Odense Investor Summit 2022!
Relive last years’ investor summit
Watch the videos and slide though the pictures from the Odense Investor Summit – Cannabis & Life Science 2022
Thank you to all participants, both pitching companies, investors and others.
We are looking forward to seeing you at this years event.
Take a look at the exciting program from our 2022-event
Why you should participate
Scale your business
As capital seeking company or investor you will get access to a relevant network amongst (fellow) investors and investor-networks.
Business development
You will get a chance to meet promising businesses in the field of medical cannabis and life science.
Networking
The focus of the events are mostly on networking and there are always plenty of time for meeting both companies and investors during the events.
Main Stage time
The most investor-ready companies will get the chance to pitch on the main stage in front of around 100 people.
want to join as a company within the field of biotech & Life SciENCE?
The sign-up for Odense Investor Summit – Biotech & Life Science is not yet available. Stay tuned for the sign-up process in the coming month.
The information you need
Capital seeking company
READ MORE
investor
READ MORE
Partner
READ MORE
Media
READ MORE
OUR valued PARTNERS
CO-FINANCED BY THE MINISTRY OF EDUCATION AND RESEARCH.
Let’s get in touch
Further information
Lone Krogsbøll
Investment Manager - Biotech & Life Science
I help foreign companies in the biotech and life science industry to establish in Odense and connect them to relevant business partners and opportunities here. My background is in health tech, but I’ve focused on broader life science sectors since 2018.